LabTurbo Biotech Corporation
LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.
LabTurbo Biotech Corporation (7725) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.064x
Based on the latest financial reports, LabTurbo Biotech Corporation (7725) has a cash flow conversion efficiency ratio of -0.064x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-77.17 Million) by net assets (NT$1.21 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
LabTurbo Biotech Corporation - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how LabTurbo Biotech Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
LabTurbo Biotech Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LabTurbo Biotech Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Viet Nam Forestry Corporation JSC
VN:VIF
|
N/A |
|
Fideicomiso Irrevocable F/2061 FHipo
MX:FHIPO14
|
N/A |
|
AALR3F
SA:AALR3F
|
N/A |
|
FIRST PACIFIC (FPC.SG)
STU:FPC
|
N/A |
|
AGP Ltd
KAR:AGP
|
0.076x |
|
Rajoo Engineers Limited
NSE:RAJOOENG
|
N/A |
|
TRINITY MIRROR
BE:MRR
|
N/A |
|
Bayn Group AB (publ)
MU:B39
|
-0.010x |
Annual Cash Flow Conversion Efficiency for LabTurbo Biotech Corporation (2021–2024)
The table below shows the annual cash flow conversion efficiency of LabTurbo Biotech Corporation from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.31 Billion | NT$-120.58 Million | -0.092x | +18.02% |
| 2023-12-31 | NT$1.34 Billion | NT$-149.59 Million | -0.112x | -119.97% |
| 2022-12-31 | NT$1.54 Billion | NT$861.34 Million | 0.561x | +132.72% |
| 2021-12-31 | NT$1.06 Billion | NT$255.53 Million | 0.241x | -- |